First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2
First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2
Recruiting · NCT07593209 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2 | cancer, neoplasm | Recruiting | Not stated | 2026-05-18 | NCT07593209 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| First Hospital of China Medical University | 92 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| PET | Shenyang | China | 1 |